Association of lifetime intellectual enrichment with cognitive decline in the older population
- PMID: 25054282
- PMCID: PMC4266551
- DOI: 10.1001/jamaneurol.2014.963
Association of lifetime intellectual enrichment with cognitive decline in the older population
Abstract
Importance: Intellectual lifestyle enrichment throughout life is increasingly viewed as a protective strategy against commonly observed cognitive decline in the older population.
Objectives: To investigate the association of lifetime intellectual enrichment with baseline cognitive performance and rate of cognitive decline in an older population without dementia and to estimate the years of protection provided against cognitive impairment by these factors.
Design, setting, and participants: Prospective analysis of individuals enrolled from October 1, 2004, and in 2008 and 2009 in the Mayo Clinic Study of Aging, a longitudinal, population-based study of cognitive aging in Olmsted County, Minnesota. We studied 1995 individuals without dementia (1718 cognitively normal individuals and 277 individuals with mild cognitive impairment) who completed intellectual lifestyle enrichment measures at baseline and underwent at least 1 follow-up visit.
Main outcomes and measures: We studied the effect of lifetime intellectual enrichment by separating the variables into 2 nonoverlapping principal components: education/occupation score and mid/late-life cognitive activity based on self-report questionnaires. A global cognitive z score served as the summary cognition measure. Linear mixed-effects models were used to investigate the associations of demographic and intellectual enrichment measures with global cognitive z score trajectories.
Results: Baseline cognitive performance was lower in older individuals; individuals with lower education/occupation score, lower mid/late-life cognitive activity, and APOE genotype; and men (P < .001). The interaction between the 2 intellectual enrichment measures was significant (P < .03) such that the beneficial effect of mid/late-life cognitive activity on baseline cognitive performance was reduced with increasing education/occupation score. Only baseline age, mid/late-life cognitive activity, and APOE4 genotype were significantly associated with longitudinal change in cognitive performance from baseline (P < .05). For APOE4 carriers with high lifetime intellectual enrichment (75th percentile of education/occupation score and midlife to late-life cognitive activity), the onset of cognitive impairment was approximately 8.7 years later compared with low lifetime intellectual enrichment (25th percentile of education/occupation score and mid/late-life cognitive activity).
Conclusions and relevance: Higher education/occupation scores were associated with higher levels of cognition. Higher levels of mid/late-life cognitive activity were also associated with higher levels of cognition, but the slope of this association slightly increased over time. Lifetime intellectual enrichment might delay the onset of cognitive impairment and be used as a successful preventive intervention to reduce the impending dementia epidemic.
Conflict of interest statement
Disclosure: The authors report no conflicts of interest
Figures
References
-
- Aging Ao. [Accessed 06/14/2013];Projected Future Growth of the Older Population. 2010 http://www.aoa.gov/Aging_Statistics/future_growth/future_growth.aspx.
-
- Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer’s disease. Jama. 1994 Apr 6;271(13):1004–1010. - PubMed
-
- Cobb JL, Wolf PA, Au R, White R, D’Agostino RB. The effect of education on the incidence of dementia and Alzheimer’s disease in the Framingham Study. Neurology. 1995 Sep;45(9):1707–1712. - PubMed
-
- Qiu C, Karp A, von Strauss E, Winblad B, Fratiglioni L, Bellander T. Lifetime principal occupation and risk of Alzheimer’s disease in the Kungsholmen project. Am J Ind Med. 2003 Feb;43(2):204–211. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 AG034676/AG/NIA NIH HHS/United States
- R01 AG011378/AG/NIA NIH HHS/United States
- C06-RR018898/RR/NCRR NIH HHS/United States
- UL1 TR000135/TR/NCATS NIH HHS/United States
- K99 AG037573/AG/NIA NIH HHS/United States
- U01-AG06786/AG/NIA NIH HHS/United States
- U01 AG006786/AG/NIA NIH HHS/United States
- R01-AG041851/AG/NIA NIH HHS/United States
- R01 AG041851/AG/NIA NIH HHS/United States
- U01 AG032438/AG/NIA NIH HHS/United States
- C06 RR018898/RR/NCRR NIH HHS/United States
- P50 AG016574/AG/NIA NIH HHS/United States
- U01 HL096917/HL/NHLBI NIH HHS/United States
- U01 AG024904/AG/NIA NIH HHS/United States
- K99/R00-AG37573/AG/NIA NIH HHS/United States
- R01 AG037551/AG/NIA NIH HHS/United States
- P50-AG16574/AG/NIA NIH HHS/United States
- R01-AG011378/AG/NIA NIH HHS/United States
- R00 AG037573/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
